MetaADEDB 2.0 @ LMMD
Retinal vascular occlusion
(UMLS:C0035326)
UMLS ID:
C0035326
MeSH ID:
N/A
Synonym(s)
1.
Retinal vascular occlusion
2.
Retinal Vascular Occlusion
3.
Retinal vascular occlusion, NOS
4.
Retinal vascular occlusion, unspecified
5.
Unspecified retinal vascular occlusion
6.
occlusion; retinal vessels
7.
retinal vascular occlusion
8.
retinal vascular occlusions
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1VancomycinFAERS: 13US FAERS
2VancomycinFAERS: 13US FAERS
3Raloxifene HydrochlorideFAERS: 6US FAERS
4valdecoxibFAERS: 6OFFSIDES
US FAERS
5Sildenafil CitrateFAERS: 4SIDER
US FAERS
6rofecoxibFAERS: 4OFFSIDES
US FAERS
7CelecoxibFAERS: 3US FAERS
8DabigatranFAERS: 3US FAERS
9LenalidomideFAERS: 3US FAERS
10RivaroxabanFAERS: 3US FAERS
11Rosuvastatin CalciumFAERS: 3US FAERS
12TestosteroneFAERS: 3US FAERS
13CrizotinibFAERS: 2US FAERS
14FluoxetineFAERS: 2US FAERS
15Glatiramer AcetateFAERS: 2US FAERS
16LetrozoleFAERS: 2US FAERS
17NorgestrelFAERS: 2US FAERS
18RisperidoneFAERS: 2US FAERS
19SorafenibFAERS: 2US FAERS
20TadalafilFAERS: 2SIDER
US FAERS
21Triamcinolone AcetonideFAERS: 2US FAERS
22VerteporfinFAERS: 2US FAERS
23Zoledronic AcidFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
24tasimelteonFAERS: 2US FAERS
25CefuroximeFAERS: 1US FAERS
26DeferasiroxFAERS: 1US FAERS
27DroxidopaFAERS: 1US FAERS
28FluticasoneFAERS: 1US FAERS
29Insulin GlargineFAERS: 1US FAERS
30Insulin degludecFAERS: 1US FAERS
31LCZ 696FAERS: 1US FAERS
32LidocaineFAERS: 1US FAERS
33OctreotideFAERS: 1OFFSIDES
US FAERS
34Ortho EvraFAERS: 1US FAERS
35PCI 32765FAERS: 1US FAERS
36PaclitaxelFAERS: 1US FAERS
37Quetiapine FumarateFAERS: 1US FAERS
38RanitidineFAERS: 1US FAERS
39SumatriptanFAERS: 1US FAERS
40TeriparatideFAERS: 1US FAERS
41TriamcinoloneFAERS: 1US FAERS
42ValsartanFAERS: 1OFFSIDES
US FAERS
43Warfarin potassiumFAERS: 1US FAERS
44apixabanFAERS: 1US FAERS
45osimertinibFAERS: 1US FAERS
46pomalidomideFAERS: 1US FAERS
47salmon calcitoninFAERS: 1US FAERS
48treprostinilFAERS: 1US FAERS
49venetoclaxFAERS: 1US FAERS
502-(Tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydron;chlorideOFFSIDES
515-[[4-[2-(5-Ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;hydron;chlorideOFFSIDES
52Aspirin-oxycodone hydrochloride-oxycodone terephthalate combinationOFFSIDES
53BupivacaineOFFSIDES
54BupropionOFFSIDES
55CaptoprilOFFSIDES
56CarbamazepineOFFSIDES
57ChlorothiazideOFFSIDES
58CisaprideOFFSIDES
59ClopidogrelOFFSIDES
60CodeineOFFSIDES
61DiphenoxylateOFFSIDES
62Estrogens, Conjugated (USP)OFFSIDES
63FluocinonideOFFSIDES
64FluorouracilOFFSIDES
65FlutamideOFFSIDES
66FosinoprilOFFSIDES
67GabapentinOFFSIDES
68GlipizideOFFSIDES
69IsradipineOFFSIDES
70LeucovorinOFFSIDES
71LoratadineOFFSIDES
72LubiprostoneOFFSIDES
73MannitolOFFSIDES
74NeomycinOFFSIDES
75NifedipineOFFSIDES
76NitrendipineOFFSIDES
77NuvaRingOFFSIDES
78PamidronateOFFSIDES
79Penicillin VOFFSIDES
80PentoxifyllineOFFSIDES
81RoxithromycinOFFSIDES
82ScopolamineOFFSIDES
83SevelamerOFFSIDES
84SumatriptanSIDER
85TacrolimusOFFSIDES
86Vitamin AOFFSIDES
87chlorhexidine gluconateOFFSIDES
88cyclobenzaprineOFFSIDES
89dexamethasone 21-phosphateOFFSIDES
90dolasetronOFFSIDES
91exemestaneOFFSIDES
92moexiprilOFFSIDES
93nilvadipineOFFSIDES
94propiomazineOFFSIDES
95reviparinOFFSIDES
96rizatriptanOFFSIDES
97rizatriptanOFFSIDES
98tegaserodOFFSIDES
99tegaserodOFFSIDES
100tipepidineOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120267

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.